U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from GEO Profiles

Items: 1 to 20 of 5025

1.
Mutant p53 reactivation restricts the protumorigenic consequences of wild type p53 loss of heterozygosity in Li-Fraumeni syndrome patient-derived fibroblasts
Himanshi Agarwal, Perry Tal, Naomi Goldfinger, Esita Chattopadhyay, David Malkin, Varda Rotter, Ayush Attery
Cell Death Differ. 2024 Jul; 31(7): 855–867. Published online 2024 May 14. doi: 10.1038/s41418-024-01307-4
PMCID:
PMC11239894
AbstractArticlePDF–4.1M
2.
p53 protein expression patterns associated with TP53 mutations in breast carcinoma
Sarah A. Anderson, Brooke B. Bartow, Shuko Harada, Gene P. Siegal, Shi Wei, Valeria L. Dal Zotto, Xiao Huang
Breast Cancer Res Treat. 2024; 207(1): 213–222. Published online 2024 Jun 20. doi: 10.1007/s10549-024-07357-z
PMCID:
PMC11230957
AbstractArticlePDF–1.5M
3.
CRL4DCAF1/VprBP E3 ubiquitin ligase controls ribosome biogenesis, cell proliferation, and development
Xiao-Ran Han, Naoya Sasaki, Sarah C. Jackson, Pu Wang, Zhijun Li, Matthew D. Smith, Ling Xie, Xian Chen, Yanping Zhang, William F. Marzluff, Yue Xiong
Sci Adv. 2020 Dec; 6(51): eabd6078. Published online 2020 Dec 18. doi: 10.1126/sciadv.abd6078
PMCID:
PMC11206221
AbstractArticlePDF–2.7M
4.
The correlation between KRAS and TP53 gene mutations and early growth of pulmonary nodules
Bin Zhao, Bin Li, Haoxin Guo, Qingtao Zhao, Xiaopeng Zhang, Huanfen Zhao, Wenfei Xue, Wei Li, Guochen Duan, Shun Xu
J Cardiothorac Surg. 2024; 19: 376. Published online 2024 Jun 26. doi: 10.1186/s13019-024-02927-0
PMCID:
PMC11200870
AbstractArticlePDF–1.0M
5.
ATM inhibition exploits checkpoint defects and ATM-dependent double strand break repair in TP53-mutant glioblastoma
Daniel J. Laverty, Shiv K. Gupta, Gary A. Bradshaw, Alexander S. Hunter, Brett L. Carlson, Nery Matias Calmo, Jiajia Chen, Shulan Tian, Jann N. Sarkaria, Zachary D. Nagel
Nat Commun. 2024; 15: 5294. Published online 2024 Jun 21. doi: 10.1038/s41467-024-49316-8
PMCID:
PMC11192742
AbstractArticlePDF–2.8M
6.
Mutant TP53 promotes invasion of lung cancer cells by regulating desmoglein 3
Yu Feng, Rulin Qian, Dong Cui, Jiaqiang Luan, Mingxing Xu, Ling Wang, Ruijie Li, Xiao Wu, Chaoying Chang
J Cancer Res Clin Oncol. 2024; 150(6): 312. Published online 2024 Jun 20. doi: 10.1007/s00432-024-05778-3
PMCID:
PMC11189974
AbstractArticlePDF–3.6M
7.
Synergistic decline in expressions of p73 and p21 with invasion in esophageal cancers
Norihiro Masuda, Hiroyuki Kato, Takashi Nakajima, Takaaki Sano, Kenji Kashiwabara, Tetsunari Oyama, Hiroyuki Kuwano
Cancer Sci. 2003 Jul; 94(7): 612–617. Published online 2005 Aug 19. doi: 10.1111/j.1349-7006.2003.tb01491.x
PMCID:
PMC11160286
AbstractArticlePDF–589K
8.
Analysis of p53, K‐ras, c‐kit, and β‐catenin gene mutations in sinonasal NK/T cell lymphoma in northeast district of China
Yoshihiko Hoshida, Tadashi Hongyo, Xinshan Jia, Yanjiao He, Kazuhisa Hasui, Zhiming Dong, Wen‐Juan Luo, Maria Francisca Ham, Taisei Nomura, Katsuyuki Aozasa
Cancer Sci. 2003 Mar; 94(3): 297–301. Published online 2005 Aug 19. doi: 10.1111/j.1349-7006.2003.tb01436.x
PMCID:
PMC11160272
AbstractArticlePDF–107K
9.
A naturally occurring p73 mutation in a p73‐p53 double‐mutant lung cancer cell line encodes p73α protein with a dominant‐negative function
Huqun, Yoshiyuki Endo, Hong Xin, Mitsu Takahashi, Toshihiro Nukiwa, Koichi Hagiwara
Cancer Sci. 2003 Aug; 94(8): 718–724. Published online 2005 Aug 19. doi: 10.1111/j.1349-7006.2003.tb01508.x
PMCID:
PMC11160092
AbstractArticlePDF–437K
10.
Comprehensive analysis of DNA repair gene polymorphisms and survival in patients with early stage non‐small‐cell lung cancer
Min Kim, Hyo‐Gyoung Kang, Shin Yup Lee, Hyung Cheol Lee, Eung Bae Lee, Yi Young Choi, Won Kee Lee, Sukki Cho, Guang Jin, Hyo‐Sung Jheon, Ji Woong Son, Myung‐Hoon Lee, Deuk Kju Jung, Seung Ick Cha, Chang Ho Kim, Young Mo Kang, Sin Kam, Tae Hoon Jung, Sanghoon Jheon, Jae Yong Park
Cancer Sci. 2010 Nov; 101(11): 2436–2442. Published online 2010 Jul 31. doi: 10.1111/j.1349-7006.2010.01699.x
PMCID:
PMC11159840
AbstractArticlePDF–209K
11.
αB‐crystallin: A novel p53‐target gene required for p53‐dependent apoptosis
Gou Watanabe, Shunsuke Kato, Hideyuki Nakata, Takanori Ishida, Noriaki Ohuchi, Chikashi Ishioka
Cancer Sci. 2009 Dec; 100(12): 2368–2375. Published online 2009 Aug 18. doi: 10.1111/j.1349-7006.2009.01316.x
PMCID:
PMC11159724
AbstractArticlePDF–512K
12.
Association of TP53 and MDM2 polymorphisms with survival in bladder cancer patients treated with chemoradiotherapy
Asano Shinohara, Shigeru Sakano, Yuji Hinoda, Jun Nishijima, Yoshihisa Kawai, Taku Misumi, Kazuhiro Nagao, Takahiko Hara, Hideyasu Matsuyama
Cancer Sci. 2009 Dec; 100(12): 2376–2382. Published online 2009 Aug 27. doi: 10.1111/j.1349-7006.2009.01331.x
PMCID:
PMC11159677
AbstractArticlePDF–200K
13.
Predictive advantage of a cell type classification for pulmonary adenocarcinoma coupled with data for p53, K‐ras and EGFR alterations
Akira Okada, Takuo Shimmyo, Takehisa Hashimoto, Yasuhito Kobayashi, Yohei Miyagi, Yuichi Ishikawa, Ken Nakagawa, Junichi Hayashi, Eiju Tsuchiya
Cancer Sci. 2010 Jul; 101(7): 1745–1753. Published online 2010 Apr 7. doi: 10.1111/j.1349-7006.2010.01585.x
PMCID:
PMC11159221
AbstractArticlePDF–366K
14.
Cytoplasmic tethering is involved in synergistic inhibition of p53 by Mdmx and Mdm2
Chihiro Ohtsubo, Daisuke Shiokawa, Masami Kodama, Christian Gaiddon, Hitoshi Nakagama, Aart G. Jochemsen, Yoichi Taya, Koji Okamoto
Cancer Sci. 2009 Jul; 100(7): 1291–1299. Published online 2009 Apr 15. doi: 10.1111/j.1349-7006.2009.01180.x
PMCID:
PMC11159218
AbstractArticlePDF–3.5M
15.
Etiologic value of p53 mutation spectra and differences with histology in lung cancers
Takuo Shimmyo, Akira Okada, Takehisa Hashimoto, Yasuhito Kobayashi, Youhei Miyagi, Yuichi Ishikawa, Ken Nakagawa, Hiroaki Osada, Eiju Tsuchiya
Cancer Sci. 2008 Feb; 99(2): 287–295. Published online 2008 Feb 6. doi: 10.1111/j.1349-7006.2007.00686.x
PMCID:
PMC11159117
AbstractArticlePDF–169K
16.
p53 Gene mutations in esophageal squamous cell carcinoma and their relevance to etiology and pathogenesis: Results in Japan and comparisons with other countries
Akinori Egashira, Masaru Morita, Yoshihiro Kakeji, Noriaki Sadanaga, Eiji Oki, Takuya Honbo, Mitsuhiko Ohta, Yoshihiko Maehara
Cancer Sci. 2007 Aug; 98(8): 1152–1156. Published online 2007 Jun 15. doi: 10.1111/j.1349-7006.2007.00524.x
PMCID:
PMC11159086
AbstractArticlePDF–110K
17.
Reactivation of p53 in cells expressing hepatitis B virus X‐protein involves p53 phosphorylation and a reduction of Hdm2
Jin‐Hee Wang, Chawon Yun, Sujeong Kim, Sunyoung Chae, Young Ik Lee, Wook‐Hwan Kim, Jae‐Ho Lee, Wankee Kim, Hyeseong Cho
Cancer Sci. 2008 May; 99(5): 888–893. Published online 2008 Feb 24. doi: 10.1111/j.1349-7006.2008.00754.x
PMCID:
PMC11159080
AbstractArticlePDF–549K
18.
Risk of p53 gene mutation in esophageal squamous cell carcinoma and habit of betel quid chewing in Taiwanese
Yih‐Gang Goan, Huang‐Chou Chang, Hon‐Ki Hsu, Yi‐Pin Chou, Jiin‐Tsuey Cheng
Cancer Sci. 2005 Nov; 96(11): 758–765. Published online 2005 Nov 4. doi: 10.1111/j.1349-7006.2005.00115.x
PMCID:
PMC11158869
AbstractArticlePDF–110K
19.
Hypoxia‐induced β‐catenin downregulation involves p53‐dependent activation of Siah‐1
Dapeng Wang, Yongxing Wang, Tao Kong, Feiyue Fan, Yongguang Jiang
Cancer Sci. 2011 Jul; 102(7): 1322–1328. Published online 2011 May 12. doi: 10.1111/j.1349-7006.2011.01950.x
PMCID:
PMC11158359
AbstractArticlePDF–765K
20.
Identification of p53–46F as a super p53 with an enhanced ability to induce p53‐dependent apoptosis
Yasuyuki Nakamura, Manabu Futamura, Hiroki Kamino, Koji Yoshida, Yusuke Nakamura, Hirofumi Arakawa
Cancer Sci. 2006 Jul; 97(7): 633–641. Published online 2006 May 15. doi: 10.1111/j.1349-7006.2006.00214.x
PMCID:
PMC11158242
AbstractArticlePDF–398K

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

You are here: NCBI > Literature > PubMed Central (PMC)
Support Center